Opposing Step-by-step Insulin Reinforcement to Intensified Strategy
NCT00174642
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
811
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Insulin Glargine
DRUG:
Insulin Glulisine
DRUG:
Metformin
DRUG:
insulin secretagogue
Sponsor
Sanofi